Atul Deodhar, MD

Professor of Medicine, Division of Arthritis and Rheumatic Diseases, School of Medicine
Oregon Health & Science University
Portland, Oregon, United States

Professor of Medicine,
Medical Director, Rheumatology Clinics

Presentation(s):

• 0567: Sonelokimab in Biologic-Experienced Patients With Active Psoriatic Arthritis: Results From a Phase 2 Trial (ARGO) and Study Design of a Phase 3 Trial (IZAR-2) in Patients With Inadequate Response or Intolerance to Biologic TNFi, Including a Risankizumab Reference Arm

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure information not submitted.

• ITS12: Taking a New Look at Psoriatic Arthritis and Its Comorbidities Through the Lens of TYK2 Inhibition

  Sunday, October 26, 2025
  5:30 PM - 7:30 PM Central Time

  Disclosure information not submitted.

• 0874: Impact of Deucravacitinib on Disease Activity in Patients With Psoriatic Arthritis (PsA): Results From the Pivotal Phase 3 PsA Studies

  Monday, October 27, 2025
  10:15 AM - 10:30 AM Central Time

  Disclosure information not submitted.